Sakar Healthcare Announces Financial Results for FY26; Appoints New Secretarial Auditors
Sakar Healthcare Limited announced the approval of its audited financial results for the quarter and year ended March 31, 2026. The Board of Directors also approved the appointment of a new firm to serve as the Company's Secretarial Auditors.The financial results include the audited consolidated and standalone statements for the fiscal year 2025-2026, which were reviewed by the audit committee and approved by the Board on May 12, 2026.
Profitability Highlights (As of March 31, 2026)
The Company reported consolidated financial results showing a Total Income of 25,402.34 lakh for the year ended March 31, 2026, compared to 17,889.74 lakh in the previous year.The detailed financials for the year ended March 31, 2026, are summarized below:
Standalone Financial Results (in lakh)
| Particulars | Year ended 31-03-2026 | Year ended 31-03-2025 |
|---|---|---|
| Total Income | 7,126.82 | 17,889.74 |
| Total Expenses | 21,426.82 | 15,731.87 |
| Profit before tax | 3,975.52 | 2,157.87 |
| Profit for the period | 1,102.43 | 1,750.20 |
Consolidated Financial Results (in lakh)
| Particulars | Year ended 31-03-2026 | Year ended 31-03-2025 |
|---|---|---|
| Total Income | 25,402.34 | 17,889.74 |
| Total Expenses | 21,426.82 | 15,731.87 |
| Profit before tax | 3,975.52 | 2,152.73 |
| Profit for the period | 3,048.46 | 1,750.20 |
Governance and Audit Appointments
In a board meeting held on May 12, 2026, the Board of Directors approved the appointment of M/s. Kashyap R. Mehta & Partners, Company Secretaries, Ahmedabad, as the Secretarial Auditors of the Company. This appointment fills a casual vacancy following the resignation of M/s. Nishant Pandya & Associates. The firm will hold office until the date of the ensuing Annual General Meeting for conducting the Secretarial Audit for the financial year 2025-26.The annual audited financial results for both standalone and consolidated accounts for the year ended March 31, 2026, received an unmodified opinion from the independent auditors.
Financial Position Summary (March 31, 2026)
The Company's consolidated balance sheet summary reflects the following assets and liabilities:Statement of Consolidated Assets and Liabilities (in lakh)
| Particulars | As at 31-03-2026 | As at 31-03-2025 |
|---|---|---|
| TOTAL ASSETS | 48,100.92 | 41,526.10 |
| EQUITY | ||
| Equity share capital | 227,499 | 219,499 |
| Other Equity (Money Received Against Share Warrant) | 3,244.52 | 2,854.75 |
| Total Equity | 32,445.25 | 28,547.59 |
| Total Liabilities | 15,655.67 | 12,978.51 |
| TOTAL EQUITY AND LIABILITIES | 48,100.92 | 41,526.10 |
Cash Flow Summary
The Statement of Cash Flows for the year ended March 31, 2026, showed net cash flow from operating activities of 4,925.80 lakh, compared to 3,403.21 lakh in the previous year.Statement of Cash Flows (in lakh)
| Particulars | 31-03-2026 | 31-03-2025 |
|---|---|---|
| Profit before Taxes | 3,975.52 | 2,152.73 |
| Net Cashflow from Operating Activity | 4,925.80 | 3,403.21 |
| Net Cashflow from Investing Activity | (2,835.22) | (3,070.92) |
| Net Cashflow from Financing Activity | (2,095.55) | (3,479.10) |
| Net Cash Inflow / (Outflow) | @97 | (15.62) |
| Closing Cash and Cash Equivalent | 25.76 | 30.73 |
SAKAR Stock Price Movement
Shares of Sakar Healthcare Limited are surging to ₹586.4 as of 3:27 PM, marking a strong gain of 10.73% in live trading today. The stock is exhibiting significant buying interest, driven by a total traded volume of 828,979 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.
Last edited by a moderator: